Company profile

Myriad Genetics Inc Insider Trading

MYGN

Every SEC Form 4 insider trading filing for Myriad Genetics Inc (MYGN) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
CIK
0000899923
Filings
179
Insiders
25
Last filing
2026-08-16

Activity summary

Recent insider activity is bearish. Over the last 30 days, insiders net sold $27K across 1 transaction.

Three year balance

Buy and sell value by quarter, Q4 23 to Q3 26. Myriad Genetics Inc insiders were net sellers in every quarter shown.

Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $6.1M.

90 day insight

Over the last 90 days, Myriad Genetics Inc insiders bought $34K (11 transactions) and sold $27K (1 transaction).

  • Most active insider: Kumar Rashmi with 2 transactions totaling $67K.
  • Largest single sale: $67K by Kumar Rashmi on Jun 8, 2026.
  • 50% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 16, 2026Wheeler Benjamin RichardMYGN
Tax Withholding
8,761$3.03$27K
Jun 11, 2026Raha Samraat S.MYGN
Award
3,542$3.94$14K
Jun 11, 2026Donnelly Brian JMYGN
Award
5,000$3.94$20K
Jun 8, 2026Kumar RashmiMYGN
Sale10b5
15,000$4.46$67K
Jun 4, 2026Reitan Colleen FMYGN
Award
59,701

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=MYGN" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Raha Samraat S.President and CEO4 filings$6K
Donnelly Brian JChief Commerical Officer2 filings$249K
Muzzey DaleChief Scientific Officer6 filings$190K
Verratti MarkChief Commercial Officer6 filings$151K
Haas Kevin RichardChief Technology Officer4 filings$104K

Institutional Ownership

Top 13F-HR holders of Myriad Genetics Inc as of 2026-06-30

↓ decreasing
Total reported AUM
$118.7M
QoQ change
-75.1%
Reporting period
2026-06-30
#1
State Street Corp
CIK 0000093751
$28.5M
5.0M shares
#2
BlackRock, Inc.
CIK 0002012383
$24.6M
4.3M shares
#3
BlackRock, Inc.
CIK 0002012383
$22.7M
4.0M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →